OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition in Cancer Metastasis
Toni Celià-Terrassa, Mohit Kumar Jolly
Cold Spring Harbor Perspectives in Medicine (2019) Vol. 10, Iss. 7, pp. a036905-a036905
Open Access | Times Cited: 132

Showing 1-25 of 132 citing articles:

TGFβ biology in cancer progression and immunotherapy
Rik Derynck, Shannon J. Turley, Rosemary J. Akhurst
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 1, pp. 9-34
Open Access | Times Cited: 647

Chemokines and their Receptors: Multifaceted Roles in Cancer Progression and Potential Value as Cancer Prognostic Markers
Hà Thị Thu, Chang Hoon Lee, Jungsook Cho
Cancers (2020) Vol. 12, Iss. 2, pp. 287-287
Open Access | Times Cited: 188

Cancer Stem Cell Plasticity – A Deadly Deal
Archana P. Thankamony, Kritika Saxena, Reshma Murali, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 139

Tumor-associated macrophages: an effective player of the tumor microenvironment
Udit Basak, Tania Sarkar, Sumon Mukherjee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 89

Cancer cell plasticity: from cellular, molecular, and genetic mechanisms to tumor heterogeneity and drug resistance
Gh. Rasool Bhat, Itty Sethi, Hana Q. Sadida, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 1, pp. 197-228
Open Access | Times Cited: 56

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance
Yena Cho, Yong Kee Kim
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 93

Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response
Michelle von Locquenghien, Catalina Rozalén, Toni Celià-Terrassa
Journal of Clinical Investigation (2021) Vol. 131, Iss. 1
Open Access | Times Cited: 91

Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma
Rama Krishna Nimmakayala, Frank Leon, Satyanarayana Rachagani, et al.
Oncogene (2020) Vol. 40, Iss. 1, pp. 215-231
Open Access | Times Cited: 85

Emerging Role of E2F Family in Cancer Stem Cells
Dan Xie, Pei Qin, Jingyuan Li, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 71

Promising applications of nanotechnology in inhibiting chemo-resistance in solid tumors by targeting epithelial-mesenchymal transition (EMT)
Mona Tangsiri, Ali Hheidari, Mahsa Liaghat, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 115973-115973
Open Access | Times Cited: 27

Deciphering the Role of Cancer Stem Cells: Drivers of Tumor Evolution, Therapeutic Resistance, and Precision Medicine Strategies
Mohamed El‐Tanani, Syed Arman Rabbani, Shakta Mani Satyam, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 382-382
Open Access | Times Cited: 1

Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy
Xiaobo Zheng, Chune Yu, Mingqing Xu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 54

Cancer-associated fibroblasts in non-small cell lung cancer: Recent advances and future perspectives
Hongfang Zhang, Hong Jiang, Lucheng Zhu, et al.
Cancer Letters (2021) Vol. 514, pp. 38-47
Closed Access | Times Cited: 52

Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Sugandha Saxena, Rakesh K. Singh
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 447-476
Open Access | Times Cited: 43

BMI1 Silencing Liposomes Suppress Postradiotherapy Cancer Stemness against Radioresistant Hepatocellular Carcinoma
M. Zhu, Haonan Fan, Junlin Deng, et al.
ACS Nano (2023) Vol. 17, Iss. 23, pp. 23405-23421
Closed Access | Times Cited: 20

The Intimate Relationship among EMT, MET and TME: A T(ransdifferentiation) E(nhancing) M(ix) to Be Exploited for Therapeutic Purposes
Ralf Hass, Juliane von der Ohe, Hendrik Ungefroren
Cancers (2020) Vol. 12, Iss. 12, pp. 3674-3674
Open Access | Times Cited: 43

Markers and Reporters to Reveal the Hierarchy in Heterogeneous Cancer Stem Cells
Amrutha Mohan, Reshma Raj Rajan, Gayathri Mohan, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 33

Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
Xiaoxiao Li, Ling Chen, Xiaobo Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27

Tumor Hybrid Cells: Nature and Biological Significance
Maria S. Tretyakova, Ayalur Raghu Subbalakshmi, Maxim E. Menyailo, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 25

Quantifying the Patterns of Metabolic Plasticity and Heterogeneity along the Epithelial–Hybrid–Mesenchymal Spectrum in Cancer
Srinath Muralidharan, Sarthak Sahoo, Aryamaan Saha, et al.
Biomolecules (2022) Vol. 12, Iss. 2, pp. 297-297
Open Access | Times Cited: 25

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c‐Myc‐mediated positive feedback loop
Xinyuan Zhao, Dalong Shu, Wenjuan Sun, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 987-1007
Open Access | Times Cited: 23

Circulating tumor cell-derived preclinical models: current status and future perspectives
Zuzana Kahounová, Markéta Pícková, Stanislav Drápela, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 16

Page 1 - Next Page

Scroll to top